Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
AstraZeneca, J&J COVID-19 vaccine trails to restart this week, Bloomberg says » 15:38
10/21/20
10/21
15:38
10/21/20
15:38
AZN

AstraZeneca

$51.82 /

-0.36 (-0.69%)

, JNJ

Johnson & Johnson

$144.30 /

-0.22 (-0.15%)

Operation Warp Speed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$51.82 /

-0.36 (-0.69%)

JNJ Johnson & Johnson
$144.30 /

-0.22 (-0.15%)

AZN AstraZeneca
$51.82 /

-0.36 (-0.69%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
JNJ Johnson & Johnson
$144.30 /

-0.22 (-0.15%)

10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
10/14/20 Cantor Fitzgerald
Johnson & Johnson price target raised to $180 from $168 at Cantor Fitzgerald
10/13/20 Wells Fargo
Emergent selloff on J&J study pause an overreaction, says Wells Fargo
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
AZN AstraZeneca
$51.82 /

-0.36 (-0.69%)

JNJ Johnson & Johnson
$144.30 /

-0.22 (-0.15%)

AZN AstraZeneca
$51.82 /

-0.36 (-0.69%)

JNJ Johnson & Johnson
$144.30 /

-0.22 (-0.15%)

AZN AstraZeneca
$51.82 /

-0.36 (-0.69%)

JNJ Johnson & Johnson
$144.30 /

-0.22 (-0.15%)

AZN AstraZeneca
$51.82 /

-0.36 (-0.69%)

JNJ Johnson & Johnson
$144.30 /

-0.22 (-0.15%)

Periodicals
Astra-Oxford COVID trial to continue in Brazil following patient death, Sky says » 14:06
10/21/20
10/21
14:06
10/21/20
14:06
AZN

AstraZeneca

$51.90 /

-0.28 (-0.54%)

After Brazil's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

AZN AstraZeneca
$51.90 /

-0.28 (-0.54%)

Periodicals
AstraZeneca trial death not on Covid vaccine, Bloomberg reports » 13:47
10/21/20
10/21
13:47
10/21/20
13:47
AZN

AstraZeneca

$51.67 /

-0.51 (-0.98%)

The deceased AstraZeneca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

AZN AstraZeneca
$51.67 /

-0.51 (-0.98%)

Periodicals
AstraZeneca trial volunteer that died not on vaccine, Bloomberg reports  13:44
10/21/20
10/21
13:44
10/21/20
13:44
AZN

AstraZeneca

$51.65 /

-0.53 (-1.02%)

 
ShowHide Related Items >><<
AZN AstraZeneca
$51.65 /

-0.53 (-1.02%)

AZN AstraZeneca
$51.65 /

-0.53 (-1.02%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$51.65 /

-0.53 (-1.02%)

AZN AstraZeneca
$51.65 /

-0.53 (-1.02%)

AZN AstraZeneca
$51.65 /

-0.53 (-1.02%)

AZN AstraZeneca
$51.65 /

-0.53 (-1.02%)

Periodicals
Participant in AstraZeneca COVID-19 trial in Brazil has died, Reuters reports » 13:04
10/21/20
10/21
13:04
10/21/20
13:04
AZN

AstraZeneca

$52.04 /

-0.14 (-0.27%)

The Brazilian health…

The Brazilian health authority, Anvisa, has said that a volunteer in a clinical trial of the COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, according to Reuters. The health authority said it had received the data about the participant's death from an investigation into the matter, the report added. Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$52.04 /

-0.14 (-0.27%)

AZN AstraZeneca
$52.04 /

-0.14 (-0.27%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$52.04 /

-0.14 (-0.27%)

AZN AstraZeneca
$52.04 /

-0.14 (-0.27%)

AZN AstraZeneca
$52.04 /

-0.14 (-0.27%)

AZN AstraZeneca
$52.04 /

-0.14 (-0.27%)

Periodicals
Brazilian authority says volunteer in AstraZeneca COVID trial died, Reuters says  13:00
10/21/20
10/21
13:00
10/21/20
13:00
AZN

AstraZeneca

$52.26 /

+0.08 (+0.15%)

 
ShowHide Related Items >><<
AZN AstraZeneca
$52.26 /

+0.08 (+0.15%)

AZN AstraZeneca
$52.26 /

+0.08 (+0.15%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$52.26 /

+0.08 (+0.15%)

AZN AstraZeneca
$52.26 /

+0.08 (+0.15%)

AZN AstraZeneca
$52.26 /

+0.08 (+0.15%)

AZN AstraZeneca
$52.26 /

+0.08 (+0.15%)

Conference/Events
Fortress Biotech management to participate in a webinar hosted by Roth Capital » 12:25
10/21/20
10/21
12:25
10/21/20
12:25
FBIO

Fortress Biotech

$2.55 /

-0.095 (-3.60%)

Roth Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBIO Fortress Biotech
$2.55 /

-0.095 (-3.60%)

FBIO Fortress Biotech
$2.55 /

-0.095 (-3.60%)

10/13/20 B. Riley Securities
Fortress Biotech weakness on Avenue CRL overblown, says B. Riley Securities
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
10/02/20 Benchmark
Fortress Biotech initiated with a Buy at Benchmark
08/21/20 B. Riley Securities
Fortress Biotech price target raised to $8 from $6 at B. Riley FBR
FBIO Fortress Biotech
$2.55 /

-0.095 (-3.60%)

Recommendations
Bayer price target lowered to EUR 68 from EUR 82 at Morgan Stanley » 11:42
10/21/20
10/21
11:42
10/21/20
11:42
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Mark Purcell lowered the firm's price target on Bayer to EUR 68 from EUR 82 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
10/02/20 Deutsche Bank
Bayer price target lowered to EUR 64 from EUR 82 at Deutsche Bank
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Periodicals
Eli Lilly hires advisor to review plant producing C-19 treatment, CNBC reports » 08:26
10/21/20
10/21
08:26
10/21/20
08:26
LLY

Eli Lilly

$143.57 /

+0.93 (+0.65%)

Eli Lilly has hired an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$143.57 /

+0.93 (+0.65%)

LLY Eli Lilly
$143.57 /

+0.93 (+0.65%)

10/16/20 JPMorgan
Eli Lilly price target raised to $200 from $190 at JPMorgan
10/14/20 JPMorgan
Eli Lilly risk/reward favorable into tirzepatide readout, says JPMorgan
10/14/20 Citi
Karuna Therapeutics trial news a positive, says Citi
10/08/20 Benchmark
Regeneron antibody data 'more convincing' than Eli Lilly's, says Benchmark
LLY Eli Lilly
$143.57 /

+0.93 (+0.65%)

LLY Eli Lilly
$143.57 /

+0.93 (+0.65%)

LLY Eli Lilly
$143.57 /

+0.93 (+0.65%)

LLY Eli Lilly
$143.57 /

+0.93 (+0.65%)

Hot Stocks
Immutep granted European patent for IMP761 » 08:23
10/21/20
10/21
08:23
10/21/20
08:23
IMMP

Immutep

$1.66 /

-0.05 (-2.92%)

Immutep announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMMP Immutep
$1.66 /

-0.05 (-2.92%)

IMMP Immutep
$1.66 /

-0.05 (-2.92%)

09/22/20
Top five analyst initiations
09/22/20 Alliance Global Partners
Immutep initiated with a Buy at Alliance Global Partners
06/02/20 JonesTrading
Immutep ASCO presentations point to expanding utility of efti, says JonesTrading

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.